Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Neogen Chemicals Limited Buy (bullish), based on 11 analysts. Average price target: ₹2,433.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 2,300 shares@ ₹2,481.80EquityMarket SaleSEBI:dfc3f166ae3f4796f32c6933bb661c50f909e12c
- 61 shares@ ₹2,425.80EquityMarket SaleSEBI:0d87bcc4a6f011ab9bbb8e34d754a3fd533abd62
- 354 shares0EquityGiftSEBI:56081e9570dba6def489f43b09751ecd66d5a327
- 354 shares0EquityGiftSEBI:0fa309fa0094b8637c7557b7b418693bb2d8c357
- 400,000 shares-MarketSEBI:7b890a48bdf47dbbd843cbaccb9100d3697b33fe
- 350,000 shares@ ₹2,000.001.00% mcap100.0% of flowEquity SharesOff MarketSEBI:5af1f2f19f402283a0149bd53edd3a49efc048aa
- 350,000 shares@ ₹2,000.001.00% mcap100.0% of flowEquity SharesOff MarketSEBI:9b256d757e443c47151f53cee3b8df8858ba51eb
- 1,000,000 shares-Pref. AllotmentSEBI:33057cf64afdd4faecf1c2a688ff54983ebde803
- 1,000,000 shares@ ₹1,610.002.71% mcap100.0% of flowEquity SharesSEBI:da823e2182321866f87d7e75ff53cf3ca2744366
- 2,019,167 sharesEquity SharesSEBI:5a8d2e8369f79c34912f750800d830f3e404031d
- 1,319,083 sharesEquity SharesSEBI:801f77173543837cffe6a2d86b89b50433eff842
- 5,778,500 sharesEquity SharesSEBI:b9e5563281bd9704c0d999d15c96f5f4fa949de7
- 5,276,500 sharesEquity SharesSEBI:864ce76572da1e4a2a037c610cce07c59df78bbb
- 502,000 sharesEquity SharesSEBI:a13e7f3ab0217ce66a3b124d032cb0b8dd253bf9
- 2,638,250 sharesEquity SharesSEBI:ed67897f8cc96e56c70c35b772298dbc15615923
- 2,638,250 sharesEquity SharesSEBI:d3c7e0fb4c714f8cdf61cab95d0dfd52d5f85934
- 6,153,887 sharesEquity SharesSEBI:4d73c6d192945d37175ce4f604641f50cc7dba1d
- 6,153,887 sharesEquity SharesSEBI:24b89af46138f3328b7e47020c2cd3b4a43da499
- 2,912,941 sharesEquity SharesSEBI:4f61462c800fa5f91f4280b9ad4ebaf2204615da
- 2,912,941 sharesEquity SharesSEBI:607eb36208e7848df16cd16494c53c2dcc7d693c
- 1,338,250 sharesEquity SharesSEBI:30a2f7775bc821c7d8ba892747a25303d5297f8a
- 1,338,250 sharesEquity SharesSEBI:fbf70db945e4ddd15a8d3ec738a4456f37cf8cef
- 1,495,000 shares@ ₹1,609.8471100.0% of flowEquity SharesSEBI:7e43a4007112e179667493a7ec1a3fb4a341da20
- 5,923 sharesEquity SharesSEBI:1298b25a79db0a5653c117c4e41cad4178354e56
- 5,923 sharesEquity SharesSEBI:2987bcd91ea73441f80d9f2b8a7320ac3863b348
25 of 27 declarations
About Neogen Chemicals Limited
Neogen Chemicals Limited is an Indian chemicals and materials company with a market capitalisation of INR 71.2 billion, 50.3% of which is held by insiders. Its record is brief: 25 filings published from September 22, 2021 to August 29, 2026, from 17 insiders, 22 of them of a kind other than purchase or sale. No purchase appears.
The 3 sales, 2 of them with an amount, total EUR 29,088,489. Haridas Thakarshi Kanani, filed as Promoter, sold EUR 26,904,739 on June 28, 2024, and Kagashin Global Network Private limited EUR 2,183,750 on September 22, 2021. Haridas Thakarshi Kanani is also the most active with 6 filings, ahead of Harin Haridas Kanani (3) and Beena Haridas Kanani (2).
Read moreShow less
Yearly volume is low until 2024 (1 to 3 filings a year), then rises to 7 in 2025 and 13 in 2026. The last twelve months count 14, of which 1 sale and no purchase. Filings are published the same day, in median.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
